"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","20/30","481/2914",9.3569262943745e-10,3.5630001233554e-07,2.4193810491287e-07,"CSNK2A1/AKT1/CTNNB1/NR0B2/CREB1/TCF7/MAPK14/GATA3/PCGF2/YAP1/CDK2/EP300/MDM2/MEN1/UBE2I/MAPK11/TWIST1/ESR2/AKT3/STAT1",20
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","20/30","499/2914",1.84611405355202e-09,3.5630001233554e-07,2.4193810491287e-07,"CSNK2A1/AKT1/CTNNB1/NR0B2/CREB1/TCF7/MAPK14/GATA3/PCGF2/YAP1/CDK2/EP300/MDM2/MEN1/UBE2I/MAPK11/TWIST1/ESR2/AKT3/STAT1",20
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","5/30","23/2914",2.41436180614541e-06,0.000198047577212665,0.000134480083790438,"DUSP9/DUSP7/DUSP10/DUSP8/DUSP2",5
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","5/30","24/2914",3.0278458601832e-06,0.000198047577212665,0.000134480083790438,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","5/30","24/2914",3.0278458601832e-06,0.000198047577212665,0.000134480083790438,"AKT1/CREB1/GSK3A/MDM2/AKT3",5
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","8/30","95/2914",3.07845974941966e-06,0.000198047577212665,0.000134480083790438,"CSNK2A1/AKT1/MAPK14/CDK2/EP300/MDM2/MAPK11/AKT3",8
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","4/30","13/2914",6.12698488042071e-06,0.000337859451977485,0.000229416426349588,"AKT1/GSK3A/MDM2/AKT3",4
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","5/30","30/2914",9.72242297202431e-06,0.000469106908400173,0.000318537278951849,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","5/30","31/2914",1.15089287523e-05,0.000493605166487535,0.000335172311031896,"AKT1/CTNNB1/TCF7/SOX6/MEN1",5
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","5/30","34/2914",1.84447443529038e-05,0.000711967132022086,0.000483446457249793,"DUSP9/DUSP7/DUSP10/DUSP8/DUSP2",5
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","4/30","21/2914",4.84270071411102e-05,0.0016993477051335,0.00115390667733363,"MAPK14/MAPK11/MEF2A/DUSP7",4
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","4/30","22/2914",5.87656420807978e-05,0.00174488752639907,0.00118482954478694,"CTNNB1/TCF7/EP300/MEN1",4
"R-HSA-525793","R-HSA-525793","Myogenesis","4/30","22/2914",5.87656420807978e-05,0.00174488752639907,0.00118482954478694,"CTNNB1/MAPK14/MAPK11/MEF2A",4
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","7/30","108/2914",7.9539751717286e-05,0.00219302458306232,0.00148912768252663,"CSNK2A1/AKT1/CTNNB1/TCF7/SOX6/EP300/MEN1",7
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","4/30","25/2914",9.94620105903097e-05,0.00255948907252397,0.0017379677639991,"AKT1/CTNNB1/PAK1/AKT3",4
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","5/30","53/2914",0.000165872530967735,0.00368660836624162,0.00250331465283382,"CTNNB1/TCF7/YAP1/EP300/MDM2",5
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","6/30","85/2914",0.000174635725469197,0.00368660836624162,0.00250331465283382,"AKT1/CTNNB1/MAPK14/MAPK11/PAK1/AKT3",6
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","4/30","29/2914",0.000181465178649199,0.00368660836624162,0.00250331465283382,"AKT1/CDK2/MDM2/AKT3",4
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","4/30","29/2914",0.000181465178649199,0.00368660836624162,0.00250331465283382,"AKT1/CDK2/MDM2/AKT3",4
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","5/30","56/2914",0.000216064183110514,0.00417003873403293,0.00283157797865885,"CSNK2A1/MAPK14/CDK2/MDM2/MAPK11",5
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","6/30","92/2914",0.000270769258958732,0.00497699685514622,0.00337952608925936,"AKT1/CTNNB1/MAPK14/MAPK11/PAK1/AKT3",6
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","12/30","397/2914",0.000295065028625827,0.00503705478863325,0.00342030717853744,"CSNK2A1/AKT1/CTNNB1/CREB1/MAPK14/PCGF2/CDK2/EP300/MAPK11/MEF2A/PAK1/AKT3",12
"R-HSA-450294","R-HSA-450294","MAP kinase activation","5/30","60/2914",0.000300135388960012,0.00503705478863325,0.00342030717853744,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","3/30","14/2914",0.000332232215580111,0.00534340146724679,0.00362832551225648,"AKT1/EP300/AKT3",3
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","5/30","62/2914",0.00035051504240274,0.00537413537052002,0.00364919472936865,"AKT1/YAP1/TWIST1/AKT3/STAT1",5
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","6/30","97/2914",0.000361988392832954,0.00537413537052002,0.00364919472936865,"AKT1/CREB1/GSK3A/MDM2/ESR2/AKT3",6
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","11/30","347/2914",0.000389161441847932,0.00556356727975192,0.00377782452320215,"AKT1/CTNNB1/CREB1/MAPK14/YAP1/MAPK11/MEF2A/PAK1/DUSP7/AKT3/STAT1",11
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","5/30","64/2914",0.000407077618223599,0.00561185573693961,0.00381061379464948,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","8/30","194/2914",0.000546930231076952,0.00727982997226564,0.00494321697053216,"CSNK2A1/AKT1/MAPK14/CDK2/EP300/MDM2/MAPK11/AKT3",8
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","5/30","70/2914",0.000618791559130821,0.00796178472748323,0.00540628414819559,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","6/30","108/2914",0.000647642101668221,0.00806418874980429,0.00547581946741551,"AKT1/CREB1/GATA3/EP300/ESR2/AKT3",6
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","5/30","78/2914",0.00101874576939394,0.0114728157800054,0.00779037668181438,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","5/30","78/2914",0.00101874576939394,0.0114728157800054,0.00779037668181438,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","5/30","78/2914",0.00101874576939394,0.0114728157800054,0.00779037668181438,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","9/30","268/2914",0.00104028122357562,0.0114728157800054,0.00779037668181438,"AKT1/CTNNB1/CREB1/GSK3A/EP300/MDM2/ESR2/AKT3/STAT1",9
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","3/30","21/2914",0.00115619259530837,0.0123969539385842,0.00841789345706971,"AKT1/PAK1/AKT3",3
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","5/30","83/2914",0.001351380830881,0.0134305835355911,0.00911975811388651,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","7/30","172/2914",0.00141249427829654,0.0134305835355911,0.00911975811388651,"CSNK2A1/AKT1/CREB1/GSK3A/MDM2/ESR2/AKT3",7
"R-HSA-195721","R-HSA-195721","Signaling by WNT","7/30","172/2914",0.00141249427829654,0.0134305835355911,0.00911975811388651,"CSNK2A1/AKT1/CTNNB1/TCF7/SOX6/EP300/MEN1",7
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","5/30","84/2914",0.00142656457243325,0.0134305835355911,0.00911975811388651,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","5/30","84/2914",0.00142656457243325,0.0134305835355911,0.00911975811388651,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","5/30","86/2914",0.00158619405061621,0.0135743986724107,0.0092174127881927,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","5/30","86/2914",0.00158619405061621,0.0135743986724107,0.0092174127881927,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","5/30","86/2914",0.00158619405061621,0.0135743986724107,0.0092174127881927,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","5/30","87/2914",0.00167079338071403,0.0135743986724107,0.0092174127881927,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","5/30","87/2914",0.00167079338071403,0.0135743986724107,0.0092174127881927,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","5/30","87/2914",0.00167079338071403,0.0135743986724107,0.0092174127881927,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/30","24/2914",0.0017231749610055,0.0135743986724107,0.0092174127881927,"AKT1/EP300/AKT3",3
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","3/30","24/2914",0.0017231749610055,0.0135743986724107,0.0092174127881927,"AKT1/CREB1/AKT3",3
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","5/30","89/2914",0.00184994859589128,0.0141630004417376,0.00961709056447413,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","3/30","25/2914",0.00194459036333485,0.0141630004417376,0.00961709056447413,"CSNK2A1/AKT1/AKT3",3
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","5/30","90/2914",0.00194466068241475,0.0141630004417376,0.00961709056447413,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","5/30","90/2914",0.00194466068241475,0.0141630004417376,0.00961709056447413,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","6/30","136/2914",0.00217347130259831,0.0155362948667213,0.0105495975506234,"AKT1/CREB1/GATA3/EP300/ESR2/AKT3",6
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","3/30","27/2914",0.00243888327400629,0.0171165262502987,0.0116226207699056,"CREB1/CDK2/EP300",3
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","7/30","201/2914",0.003476797439999,0.0238488775549509,0.0161940837501575,"CSNK2A1/AKT1/CREB1/GSK3A/MDM2/ESR2/AKT3",7
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","4/30","63/2914",0.00356717867147725,0.0238488775549509,0.0161940837501575,"AKT1/CREB1/ESR2/AKT3",4
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","3/30","31/2914",0.00364529475580855,0.0238488775549509,0.0161940837501575,"AKT1/PAK1/AKT3",3
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","3/30","31/2914",0.00364529475580855,0.0238488775549509,0.0161940837501575,"AKT1/MAPK14/MAPK11",3
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","2/30","10/2914",0.00438128949482354,0.0277242253278998,0.018825557967404,"MAPK14/MAPK11",2
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","2/30","10/2914",0.00438128949482354,0.0277242253278998,0.018825557967404,"AKT1/AKT3",2
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","5/30","110/2914",0.00468627412047233,0.0287451069617367,0.0195187663852534,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","9/30","332/2914",0.00469155890826272,0.0287451069617367,0.0195187663852534,"AKT1/CREB1/MAPK14/GATA3/MAPK11/MEF2A/TWIST1/DUSP7/STAT1",9
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","3/30","35/2914",0.00516251623443024,0.0302030002508637,0.0205087184686803,"MAPK14/MAPK11/PAK1",3
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","2/30","11/2914",0.00532073579548894,0.0302030002508637,0.0205087184686803,"AKT1/AKT3",2
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","2/30","11/2914",0.00532073579548894,0.0302030002508637,0.0205087184686803,"AKT1/AKT3",2
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","2/30","11/2914",0.00532073579548894,0.0302030002508637,0.0205087184686803,"CREB1/EP300",2
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","2/30","11/2914",0.00532073579548894,0.0302030002508637,0.0205087184686803,"AKT1/AKT3",2
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","3/30","37/2914",0.00604437525585505,0.0338134615762326,0.0229603270588544,"PCGF2/EP300/UBE2I",3
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","3/30","38/2914",0.00651714445495769,0.0359373965659096,0.0244025408914957,"CREB1/MAPK14/MAPK11",3
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","3/30","39/2914",0.00701149365748871,0.0381188246731076,0.025883794228535,"AKT1/CDK2/AKT3",3
"R-HSA-171007","R-HSA-171007","p38MAPK events","2/30","13/2914",0.00744984945364489,0.0382326443294464,0.0259610810963516,"MAPK14/MAPK11",2
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","2/30","13/2914",0.00744984945364489,0.0382326443294464,0.0259610810963516,"CTNNB1/MEN1",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/30","13/2914",0.00744984945364489,0.0382326443294464,0.0259610810963516,"EP300/MDM2",2
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","2/30","13/2914",0.00744984945364489,0.0382326443294464,0.0259610810963516,"AKT1/AKT3",2
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","3/30","40/2914",0.00752767090424333,0.0382326443294464,0.0259610810963516,"AKT1/CDK2/AKT3",3
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","5/30","127/2914",0.00860753681307658,0.0431494702577605,0.0292997493705546,"CREB1/MAPK14/MAPK11/MEF2A/DUSP7",5
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","5/30","130/2914",0.00948318704267067,0.0469296179291139,0.0318665799409581,"CTNNB1/MAPK14/MEN1/MAPK11/PAK1",5
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","3/30","44/2914",0.00981515976720709,0.0477737983143392,0.0324398030550053,"MAPK14/MDM2/MAPK11",3
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","2/30","15/2914",0.00990130535012211,0.0477737983143392,0.0324398030550053,"AKT1/AKT3",2
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","4/30","86/2914",0.010787998108948,0.0504662212960124,0.0342680368222173,"CSNK2A1/GATA3/YAP1/EP300",4
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","7/30","249/2914",0.0112404298144311,0.0504662212960124,0.0342680368222173,"CSNK2A1/AKT1/CDK2/EP300/MDM2/UBE2I/AKT3",7
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","2/30","16/2914",0.0112437695115468,0.0504662212960124,0.0342680368222173,"MDM2/UBE2I",2
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","2/30","16/2914",0.0112437695115468,0.0504662212960124,0.0342680368222173,"AKT1/AKT3",2
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","2/30","16/2914",0.0112437695115468,0.0504662212960124,0.0342680368222173,"MAPK14/MAPK11",2
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","2/30","16/2914",0.0112437695115468,0.0504662212960124,0.0342680368222173,"EP300/MDM2",2
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","2/30","17/2914",0.0126618959042917,0.0555396797620068,0.0377130631599119,"MDM2/UBE2I",2
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","2/30","17/2914",0.0126618959042917,0.0555396797620068,0.0377130631599119,"PCGF2/UBE2I",2
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","3/30","49/2914",0.0131900652709494,0.0572063505009717,0.0388447812237304,"AKT1/EP300/AKT3",3
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/30","18/2914",0.0141540921105686,0.0600382368646097,0.0407677146967216,"CSNK2A1/EP300",2
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","2/30","18/2914",0.0141540921105686,0.0600382368646097,0.0407677146967216,"EP300/STAT1",2
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","4/30","94/2914",0.0146313731907545,0.0613881527351223,0.0416843469622183,"AKT1/GATA3/TWIST1/STAT1",4
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","6/30","202/2914",0.0150091911191889,0.0622962126022248,0.0423009461084101,"DUSP9/PAK1/DUSP7/DUSP10/DUSP8/DUSP2",6
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","2/30","19/2914",0.0157187885875113,0.0638679199450457,0.0433681812552942,"AKT1/AKT3",2
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","2/30","19/2914",0.0157187885875113,0.0638679199450457,0.0433681812552942,"EP300/PAK1",2
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","3/30","53/2914",0.0163140826212975,0.0655962072064672,0.0445417387357795,"AKT1/PAK1/AKT3",3
"R-HSA-167044","R-HSA-167044","Signalling to RAS","2/30","20/2914",0.0173544383896317,0.0679511978699123,0.0461408461129211,"MAPK14/MAPK11",2
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","2/30","20/2914",0.0173544383896317,0.0679511978699123,0.0461408461129211,"CSNK2A1/PAK1",2
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","4/30","99/2914",0.017427897899278,0.0679511978699123,0.0461408461129211,"MAPK14/CDK2/MDM2/MAPK11",4
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","2/30","21/2914",0.0190595168942973,0.0728413219920669,0.0494613830816053,"AKT1/AKT3",2
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","2/30","21/2914",0.0190595168942973,0.0728413219920669,0.0494613830816053,"MAPK14/MAPK11",2
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","4/30","104/2914",0.0205416739088626,0.0765843172443464,0.0520029860753811,"AKT1/CREB1/EP300/STAT1",4
"R-HSA-1500620","R-HSA-1500620","Meiosis","2/30","22/2914",0.0208325215301979,0.0765843172443464,0.0520029860753811,"CDK2/UBE2I",2
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","2/30","22/2914",0.0208325215301979,0.0765843172443464,0.0520029860753811,"CDK2/MDM2",2
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","2/30","22/2914",0.0208325215301979,0.0765843172443464,0.0520029860753811,"CDK2/MDM2",2
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","3/30","59/2914",0.0217216953873238,0.0790997586745944,0.0537110442050014,"CSNK2A1/AKT1/AKT3",3
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","4/30","107/2914",0.0225663544964062,0.08041516560102,0.0546042438905208,"PCGF2/EP300/MDM2/UBE2I",4
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","2/30","23/2914",0.022671971508773,0.08041516560102,0.0546042438905208,"PCGF2/UBE2I",2
"R-HSA-69206","R-HSA-69206","G1/S Transition","3/30","60/2914",0.0227079094572828,0.08041516560102,0.0546042438905208,"AKT1/CDK2/AKT3",3
"R-HSA-2990846","R-HSA-2990846","SUMOylation","4/30","109/2914",0.0239824853073819,0.083951268297416,0.0570053608018996,"PCGF2/EP300/MDM2/UBE2I",4
"R-HSA-1474165","R-HSA-1474165","Reproduction","2/30","24/2914",0.02457640755857,0.083951268297416,0.0570053608018996,"CDK2/UBE2I",2
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","2/30","24/2914",0.02457640755857,0.083951268297416,0.0570053608018996,"CDK2/MDM2",2
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","2/30","24/2914",0.02457640755857,0.083951268297416,0.0570053608018996,"AKT1/AKT3",2
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","2/30","25/2914",0.0265443916625035,0.0890968276671856,0.0604993457571018,"EP300/UBE2I",2
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","2/30","25/2914",0.0265443916625035,0.0890968276671856,0.0604993457571018,"AKT1/AKT3",2
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","5/30","171/2914",0.0282794673442566,0.0941023654731297,0.063898251984754,"DUSP9/DUSP7/DUSP10/DUSP8/DUSP2",5
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","2/30","26/2914",0.0285745067979864,0.0942714497779722,0.064013065161481,"TWIST1/STAT1",2
"R-HSA-1643685","R-HSA-1643685","Disease","9/30","443/2914",0.0293345203223776,0.0959586851223539,0.0651587471924355,"AKT1/CTNNB1/CREB1/GSK3A/EP300/MDM2/ESR2/AKT3/STAT1",9
"R-HSA-165159","R-HSA-165159","mTOR signalling","2/30","27/2914",0.0306653566799048,0.0970231776921578,0.0658815687083373,"AKT1/RPS6KB1",2
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","2/30","27/2914",0.0306653566799048,0.0970231776921578,0.0658815687083373,"PCGF2/EP300",2
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","2/30","27/2914",0.0306653566799048,0.0970231776921578,0.0658815687083373,"PCGF2/EP300",2
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","2/30","27/2914",0.0306653566799048,0.0970231776921578,0.0658815687083373,"GATA3/YAP1",2
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","5/30","177/2914",0.0322378261668695,0.101169113011477,0.0686967797650877,"DUSP9/DUSP7/DUSP10/DUSP8/DUSP2",5
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","2/30","29/2914",0.0350237777074806,0.107720787907821,0.073145558192112,"AKT1/AKT3",2
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","2/30","29/2914",0.0350237777074806,0.107720787907821,0.073145558192112,"CREB1/EP300",2
"R-HSA-69242","R-HSA-69242","S Phase","3/30","71/2914",0.0351627442393406,0.107720787907821,0.073145558192112,"AKT1/CDK2/AKT3",3
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","2/30","30/2914",0.0372886576962838,0.113334030478469,0.0769571136873159,"CDK2/EP300",2
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","5/30","187/2914",0.0395912505278661,0.119392364873096,0.0810708995184101,"MAPK14/CDK2/EP300/MDM2/MAPK11",5
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","5/30","188/2914",0.0403796016197142,0.120825784691548,0.0820442334011329,"DUSP9/DUSP7/DUSP10/DUSP8/DUSP2",5
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","5/30","189/2914",0.0411777036808392,0.122266104775415,0.0830222527654166,"MAPK14/CDK2/EP300/MDM2/MAPK11",5
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","5/30","191/2914",0.0428032594454546,0.126122581266759,0.0856409128318055,"CSNK2A1/AKT1/CDK2/EP300/AKT3",5
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","3/30","77/2914",0.0431874406703767,0.126290546202768,0.0857549659244322,"AKT1/CDK2/AKT3",3
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","2/30","33/2914",0.0444102431225021,0.12792801377079,0.086866854183056,"MAPK14/MAPK11",2
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","2/30","33/2914",0.0444102431225021,0.12792801377079,0.086866854183056,"MAPK14/MAPK11",2
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","2/30","34/2914",0.0468888295061011,0.134067319921148,0.09103562219898,"CTNNB1/EP300",2
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/30","80/2914",0.0475195818193997,0.134871754281532,0.0915818566024035,"CREB1/MAPK14/MAPK11",3
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","2/30","35/2914",0.0494176969771115,0.139235263015803,0.0945448063565175,"AKT1/AKT3",2
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","2/30","37/2914",0.0546214104636513,0.151682477978197,0.102996828515329,"CTNNB1/TCF7",2
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","2/30","37/2914",0.0546214104636513,0.151682477978197,0.102996828515329,"EP300/STAT1",2
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","2/30","38/2914",0.0572938696863565,0.157967383563811,0.107264462796261,"PCGF2/UBE2I",2
"R-HSA-168249","R-HSA-168249","Innate Immune System","8/30","428/2914",0.0620254395758927,0.169446335159428,0.115059005875914,"CTNNB1/CREB1/MAPK14/EP300/MAPK11/MEF2A/PAK1/DUSP7",8
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","2/30","40/2914",0.0627741604347105,0.169446335159428,0.115059005875914,"CTNNB1/TCF7",2
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","2/30","40/2914",0.0627741604347105,0.169446335159428,0.115059005875914,"AKT1/EP300",2
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","2/30","44/2914",0.0742446687199414,0.199016959207621,0.13513832245077,"AKT1/AKT3",2
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","3/30","99/2914",0.0796748266956048,0.210639050588005,0.143030061620979,"AKT1/ESR2/AKT3",3
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","5/30","228/2914",0.0800716742080748,0.210639050588005,0.143030061620979,"CTNNB1/MAPK14/MEN1/MAPK11/PAK1",5
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","2/30","46/2914",0.0802174622705613,0.210639050588005,0.143030061620979,"NR0B2/ESR2",2
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","2/30","47/2914",0.083259562872766,0.214895119658216,0.145920056708197,"AKT1/CDK2",2
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","2/30","47/2914",0.083259562872766,0.214895119658216,0.145920056708197,"AKT1/CDK2",2
"R-HSA-109581","R-HSA-109581","Apoptosis","3/30","101/2914",0.0835084661884258,0.214895119658216,0.145920056708197,"AKT1/CTNNB1/AKT3",3
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","2/30","48/2914",0.0863374401392162,0.219251657195641,0.148878272816238,"MAPK14/MAPK11",2
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","2/30","48/2914",0.0863374401392162,0.219251657195641,0.148878272816238,"CDK2/UBE2I",2
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","3/30","103/2914",0.0874223398186446,0.220555706993443,0.149763760680031,"AKT1/CTNNB1/AKT3",3
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","2/30","49/2914",0.0894500943889296,0.222759589897592,0.151260261479412,"AKT1/AKT3",2
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","2/30","49/2914",0.0894500943889296,0.222759589897592,0.151260261479412,"GATA3/EP300",2
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","1/30","10/2914",0.0984554983614546,0.231569480903053,0.157242434537388,"UBE2I",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/30","10/2914",0.0984554983614546,0.231569480903053,0.157242434537388,"GSK3A",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/30","10/2914",0.0984554983614546,0.231569480903053,0.157242434537388,"CREB1",1
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","1/30","10/2914",0.0984554983614546,0.231569480903053,0.157242434537388,"UBE2I",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/30","10/2914",0.0984554983614546,0.231569480903053,0.157242434537388,"EP300",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/30","10/2914",0.0984554983614546,0.231569480903053,0.157242434537388,"CSNK2A1",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/30","10/2914",0.0984554983614546,0.231569480903053,0.157242434537388,"STAT1",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/30","10/2914",0.0984554983614546,0.231569480903053,0.157242434537388,"STAT1",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/30","10/2914",0.0984554983614546,0.231569480903053,0.157242434537388,"EP300",1
"R-HSA-400253","R-HSA-400253","Circadian Clock","2/30","52/2914",0.0989869542720306,0.231569480903053,0.157242434537388,"CREB1/EP300",2
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","3/30","109/2914",0.0996301056837357,0.231670004782663,0.157310693184846,"AKT1/MAPK14/MAPK11",3
"R-HSA-373760","R-HSA-373760","L1CAM interactions","2/30","53/2914",0.102229027670099,0.236289848387174,0.16044770179549,"CSNK2A1/PAK1",2
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/30","11/2914",0.107768974618051,0.24020166580056,0.163103939962747,"STAT1",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/30","11/2914",0.107768974618051,0.24020166580056,0.163103939962747,"EP300",1
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","1/30","11/2914",0.107768974618051,0.24020166580056,0.163103939962747,"PAK1",1
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","1/30","11/2914",0.107768974618051,0.24020166580056,0.163103939962747,"CDK2",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/30","11/2914",0.107768974618051,0.24020166580056,0.163103939962747,"STAT1",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","2/30","55/2914",0.108802288861826,0.24020166580056,0.163103939962747,"EP300/UBE2I",2
"R-HSA-422475","R-HSA-422475","Axon guidance","5/30","254/2914",0.114389157746986,0.24020166580056,0.163103939962747,"CSNK2A1/CREB1/MAPK14/MAPK11/PAK1",5
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"CREB1",1
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"CSNK2A1",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"STAT1",1
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"DUSP7",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"YAP1",1
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"EP300",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"GSK3A",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"CTNNB1",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"PAK1",1
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"PAK1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"CTNNB1",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"CREB1",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"CDK2",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/30","12/2914",0.116989412358822,0.24020166580056,0.163103939962747,"CREB1",1
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","3/30","119/2914",0.121434143966967,0.244630330539138,0.166111132544983,"CSNK2A1/EP300/UBE2I",3
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","2/30","59/2914",0.122280308592074,0.244630330539138,0.166111132544983,"CDK2/UBE2I",2
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/30","13/2914",0.126117709267587,0.244630330539138,0.166111132544983,"CREB1",1
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/30","13/2914",0.126117709267587,0.244630330539138,0.166111132544983,"EP300",1
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","1/30","13/2914",0.126117709267587,0.244630330539138,0.166111132544983,"UBE2I",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/30","13/2914",0.126117709267587,0.244630330539138,0.166111132544983,"PAK1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/30","13/2914",0.126117709267587,0.244630330539138,0.166111132544983,"EP300",1
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","1/30","13/2914",0.126117709267587,0.244630330539138,0.166111132544983,"EP300",1
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","1/30","13/2914",0.126117709267587,0.244630330539138,0.166111132544983,"PAK1",1
"R-HSA-912446","R-HSA-912446","Meiotic recombination","1/30","13/2914",0.126117709267587,0.244630330539138,0.166111132544983,"CDK2",1
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","1/30","13/2914",0.126117709267587,0.244630330539138,0.166111132544983,"EP300",1
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","2/30","62/2914",0.13265190583551,0.247249930350207,0.167889917254436,"GATA3/CDK2",2
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","3/30","124/2914",0.132964759820641,0.247249930350207,0.167889917254436,"GATA3/EP300/MDM2",3
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/30","14/2914",0.1351547546733,0.247249930350207,0.167889917254436,"CTNNB1",1
"R-HSA-445355","R-HSA-445355","Smooth Muscle Contraction","1/30","14/2914",0.1351547546733,0.247249930350207,0.167889917254436,"PAK1",1
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","1/30","14/2914",0.1351547546733,0.247249930350207,0.167889917254436,"CTNNB1",1
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","1/30","14/2914",0.1351547546733,0.247249930350207,0.167889917254436,"CTNNB1",1
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","1/30","14/2914",0.1351547546733,0.247249930350207,0.167889917254436,"CTNNB1",1
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","1/30","14/2914",0.1351547546733,0.247249930350207,0.167889917254436,"CTNNB1",1
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","1/30","14/2914",0.1351547546733,0.247249930350207,0.167889917254436,"CTNNB1",1
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","1/30","14/2914",0.1351547546733,0.247249930350207,0.167889917254436,"CTNNB1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/30","14/2914",0.1351547546733,0.247249930350207,0.167889917254436,"STAT1",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/30","14/2914",0.1351547546733,0.247249930350207,0.167889917254436,"EP300",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","2/30","63/2914",0.136154829648391,0.24790454832207,0.168334421958537,"CDK2/UBE2I",2
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/30","15/2914",0.144101429624955,0.253986994681428,0.17246458051725,"YAP1",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/30","15/2914",0.144101429624955,0.253986994681428,0.17246458051725,"MAPK14",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/30","15/2914",0.144101429624955,0.253986994681428,0.17246458051725,"EP300",1
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","1/30","15/2914",0.144101429624955,0.253986994681428,0.17246458051725,"EP300",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/30","15/2914",0.144101429624955,0.253986994681428,0.17246458051725,"MDM2",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/30","15/2914",0.144101429624955,0.253986994681428,0.17246458051725,"CTNNB1",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/30","15/2914",0.144101429624955,0.253986994681428,0.17246458051725,"AKT1",1
"R-HSA-69275","R-HSA-69275","G2/M Transition","2/30","66/2914",0.146789768051146,0.25754932030792,0.174883503563327,"CDK2/EP300",2
"R-HSA-166208","R-HSA-166208","mTORC1-mediated signalling","1/30","16/2914",0.152958606965849,0.261247886233707,0.177394937748004,"RPS6KB1",1
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/30","16/2914",0.152958606965849,0.261247886233707,0.177394937748004,"CDK2",1
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","1/30","16/2914",0.152958606965849,0.261247886233707,0.177394937748004,"CTNNB1",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/30","16/2914",0.152958606965849,0.261247886233707,0.177394937748004,"PAK1",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/30","16/2914",0.152958606965849,0.261247886233707,0.177394937748004,"CSNK2A1",1
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","1/30","16/2914",0.152958606965849,0.261247886233707,0.177394937748004,"PAK1",1
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","2/30","68/2914",0.153977290002588,0.261829224409688,0.177789683332458,"CDK2/EP300",2
"R-HSA-399719","R-HSA-399719","Trafficking of AMPA receptors","1/30","17/2914",0.161727151407196,0.269080519151628,0.182713524048965,"MDM2",1
"R-HSA-399721","R-HSA-399721","Glutamate binding, activation of AMPA receptors and synaptic plasticity","1/30","17/2914",0.161727151407196,0.269080519151628,0.182713524048965,"MDM2",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/30","17/2914",0.161727151407196,0.269080519151628,0.182713524048965,"MAPK14",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/30","17/2914",0.161727151407196,0.269080519151628,0.182713524048965,"CDK2",1
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","1/30","17/2914",0.161727151407196,0.269080519151628,0.182713524048965,"EP300",1
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","2/30","72/2914",0.16856031767537,0.277542012514897,0.18845912494194,"EP300/PAK1",2
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/30","18/2914",0.170407919601115,0.277542012514897,0.18845912494194,"PAK1",1
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","1/30","18/2914",0.170407919601115,0.277542012514897,0.18845912494194,"CDK2",1
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","1/30","18/2914",0.170407919601115,0.277542012514897,0.18845912494194,"CREB1",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/30","18/2914",0.170407919601115,0.277542012514897,0.18845912494194,"PCGF2",1
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","1/30","19/2914",0.179001760212982,0.284340244618153,0.193075322906791,"CDK2",1
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/30","19/2914",0.179001760212982,0.284340244618153,0.193075322906791,"EP300",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/30","19/2914",0.179001760212982,0.284340244618153,0.193075322906791,"CTNNB1",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/30","19/2914",0.179001760212982,0.284340244618153,0.193075322906791,"CSNK2A1",1
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","1/30","19/2914",0.179001760212982,0.284340244618153,0.193075322906791,"YAP1",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/30","19/2914",0.179001760212982,0.284340244618153,0.193075322906791,"EP300",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","2/30","76/2914",0.183383944910091,0.290107388259407,0.196991381719641,"CTNNB1/TCF7",2
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","2/30","77/2914",0.187122518356484,0.294222245533981,0.199785489877178,"CREB1/MDM2",2
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/30","20/2914",0.187509513993159,0.294222245533981,0.199785489877178,"EP300",1
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/30","21/2914",0.195932013848102,0.304958698973255,0.207075855043198,"CTNNB1",1
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","1/30","21/2914",0.195932013848102,0.304958698973255,0.207075855043198,"UBE2I",1
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","2/30","80/2914",0.198406655936043,0.30757015739483,0.208849111511625,"GATA3/MDM2",2
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/30","81/2914",0.202188840887057,0.310426192029889,0.210788442365537,"CDK2/UBE2I",2
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/30","22/2914",0.204270084910859,0.310426192029889,0.210788442365537,"CDK2",1
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","1/30","22/2914",0.204270084910859,0.310426192029889,0.210788442365537,"CREB1",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/30","22/2914",0.204270084910859,0.310426192029889,0.210788442365537,"CREB1",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/30","22/2914",0.204270084910859,0.310426192029889,0.210788442365537,"EP300",1
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","6/30","393/2914",0.209564935646732,0.315513830589093,0.214243097400284,"GATA3/PCGF2/EP300/MDM2/MEN1/UBE2I",6
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","1/30","23/2914",0.212524544610954,0.315513830589093,0.214243097400284,"EP300",1
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","1/30","23/2914",0.212524544610954,0.315513830589093,0.214243097400284,"MDM2",1
"R-HSA-392518","R-HSA-392518","Signal amplification","1/30","23/2914",0.212524544610954,0.315513830589093,0.214243097400284,"MAPK14",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/30","23/2914",0.212524544610954,0.315513830589093,0.214243097400284,"STAT1",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/30","23/2914",0.212524544610954,0.315513830589093,0.214243097400284,"CDK2",1
"R-HSA-73894","R-HSA-73894","DNA Repair","3/30","157/2914",0.217392165620401,0.315513830589093,0.214243097400284,"CDK2/EP300/UBE2I",3
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/30","24/2914",0.220696202743666,0.315513830589093,0.214243097400284,"EP300",1
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/30","24/2914",0.220696202743666,0.315513830589093,0.214243097400284,"STAT1",1
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","1/30","24/2914",0.220696202743666,0.315513830589093,0.214243097400284,"MEN1",1
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/30","24/2914",0.220696202743666,0.315513830589093,0.214243097400284,"CDK2",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/30","24/2914",0.220696202743666,0.315513830589093,0.214243097400284,"PAK1",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/30","24/2914",0.220696202743666,0.315513830589093,0.214243097400284,"STAT1",1
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","1/30","24/2914",0.220696202743666,0.315513830589093,0.214243097400284,"YAP1",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/30","24/2914",0.220696202743666,0.315513830589093,0.214243097400284,"STAT1",1
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","1/30","24/2914",0.220696202743666,0.315513830589093,0.214243097400284,"STAT1",1
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","1/30","25/2914",0.228785861538715,0.32128808845313,0.218163986977991,"CREB1",1
"R-HSA-111997","R-HSA-111997","CaM pathway","1/30","25/2914",0.228785861538715,0.32128808845313,0.218163986977991,"CREB1",1
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/30","25/2914",0.228785861538715,0.32128808845313,0.218163986977991,"AKT1",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/30","25/2914",0.228785861538715,0.32128808845313,0.218163986977991,"AKT1",1
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","2/30","88/2914",0.228896954208836,0.32128808845313,0.218163986977991,"CREB1/MDM2",2
"R-HSA-111996","R-HSA-111996","Ca-dependent events","1/30","26/2914",0.236794315728344,0.328786352054463,0.223255526756371,"CREB1",1
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","1/30","26/2914",0.236794315728344,0.328786352054463,0.223255526756371,"AKT1",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/30","26/2914",0.236794315728344,0.328786352054463,0.223255526756371,"CTNNB1",1
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","2/30","92/2914",0.244294772729119,0.336166648075877,0.22826696310579,"AKT1/ESR2",2
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","1/30","27/2914",0.244722352614822,0.336166648075877,0.22826696310579,"YAP1",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/30","27/2914",0.244722352614822,0.336166648075877,0.22826696310579,"CDK2",1
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","1/30","28/2914",0.252570752137356,0.342078281842173,0.232281134929646,"UBE2I",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/30","28/2914",0.252570752137356,0.342078281842173,0.232281134929646,"EP300",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/30","28/2914",0.252570752137356,0.342078281842173,0.232281134929646,"UBE2I",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/30","28/2914",0.252570752137356,0.342078281842173,0.232281134929646,"EP300",1
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","1/30","29/2914",0.260340286938423,0.348928301243859,0.23693249798124,"STAT1",1
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","1/30","29/2914",0.260340286938423,0.348928301243859,0.23693249798124,"EP300",1
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","1/30","29/2914",0.260340286938423,0.348928301243859,0.23693249798124,"GSK3A",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/30","30/2914",0.268031722429531,0.351905594754418,0.238954167149851,"CSNK2A1",1
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","1/30","30/2914",0.268031722429531,0.351905594754418,0.238954167149851,"CREB1",1
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","1/30","30/2914",0.268031722429531,0.351905594754418,0.238954167149851,"PAK1",1
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","1/30","30/2914",0.268031722429531,0.351905594754418,0.238954167149851,"CSNK2A1",1
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","1/30","30/2914",0.268031722429531,0.351905594754418,0.238954167149851,"CTNNB1",1
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","1/30","30/2914",0.268031722429531,0.351905594754418,0.238954167149851,"UBE2I",1
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/30","31/2914",0.275645816856409,0.357044581565684,0.242443689146046,"AKT1",1
"R-HSA-391251","R-HSA-391251","Protein folding","1/30","31/2914",0.275645816856409,0.357044581565684,0.242443689146046,"CSNK2A1",1
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","1/30","31/2914",0.275645816856409,0.357044581565684,0.242443689146046,"CTNNB1",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/30","31/2914",0.275645816856409,0.357044581565684,0.242443689146046,"STAT1",1
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/30","32/2914",0.283183321363626,0.361949543199866,0.245774301218344,"CREB1",1
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","1/30","32/2914",0.283183321363626,0.361949543199866,0.245774301218344,"CREB1",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/30","32/2914",0.283183321363626,0.361949543199866,0.245774301218344,"STAT1",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/30","32/2914",0.283183321363626,0.361949543199866,0.245774301218344,"EP300",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/30","33/2914",0.290644980058661,0.366369970092696,0.248775900062943,"EP300",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/30","33/2914",0.290644980058661,0.366369970092696,0.248775900062943,"CDK2",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/30","33/2914",0.290644980058661,0.366369970092696,0.248775900062943,"AKT1",1
"R-HSA-112316","R-HSA-112316","Neuronal System","2/30","105/2914",0.294599961438446,0.366369970092696,0.248775900062943,"CREB1/MDM2",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","1/30","34/2914",0.298031530075405,0.366369970092696,0.248775900062943,"CREB1",1
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","1/30","34/2914",0.298031530075405,0.366369970092696,0.248775900062943,"CREB1",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/30","34/2914",0.298031530075405,0.366369970092696,0.248775900062943,"STAT1",1
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/30","34/2914",0.298031530075405,0.366369970092696,0.248775900062943,"CDK2",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/30","34/2914",0.298031530075405,0.366369970092696,0.248775900062943,"EP300",1
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","1/30","34/2914",0.298031530075405,0.366369970092696,0.248775900062943,"PAK1",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/30","34/2914",0.298031530075405,0.366369970092696,0.248775900062943,"PAK1",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/30","34/2914",0.298031530075405,0.366369970092696,0.248775900062943,"UBE2I",1
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/30","35/2914",0.30534370163712,0.371806526283686,0.252467480350798,"STAT1",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/30","35/2914",0.30534370163712,0.371806526283686,0.252467480350798,"CTNNB1",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/30","35/2914",0.30534370163712,0.371806526283686,0.252467480350798,"UBE2I",1
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","1/30","36/2914",0.312582218118845,0.379423698722875,0.257639762699743,"MEN1",1
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","1/30","37/2914",0.319747796109267,0.386904856734097,0.262719687283311,"EP300",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/30","38/2914",0.326841145472049,0.394252131725659,0.267708701389934,"PAK1",1
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","2/30","114/2914",0.329311405935575,0.395994400906953,0.268891753001994,"CDK2/MDM2",2
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/30","39/2914",0.333862969406624,0.40022082667999,0.271761619425463,"EP300",1
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/30","40/2914",0.340813964508468,0.403540461043769,0.27401574802263,"CDK2",1
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","1/30","40/2914",0.340813964508468,0.403540461043769,0.27401574802263,"EP300",1
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","1/30","40/2914",0.340813964508468,0.403540461043769,0.27401574802263,"EP300",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/30","40/2914",0.340813964508468,0.403540461043769,0.27401574802263,"CDK2",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","4/30","289/2914",0.346577129917563,0.406697578302823,0.276159522763575,"CSNK2A1/AKT1/EP300/UBE2I",4
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","1/30","41/2914",0.347694820828839,0.406697578302823,0.276159522763575,"STAT1",1
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","1/30","41/2914",0.347694820828839,0.406697578302823,0.276159522763575,"STAT1",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/30","41/2914",0.347694820828839,0.406697578302823,0.276159522763575,"CREB1",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/30","42/2914",0.354506221934002,0.410929134133708,0.279032872646014,"CTNNB1",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/30","42/2914",0.354506221934002,0.410929134133708,0.279032872646014,"MAPK14",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/30","42/2914",0.354506221934002,0.410929134133708,0.279032872646014,"STAT1",1
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","1/30","43/2914",0.361248844963939,0.417491180108026,0.283488693337601,"PAK1",1
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","1/30","44/2914",0.367923360690544,0.422165384913386,0.286662614789836,"YAP1",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/30","44/2914",0.367923360690544,0.422165384913386,0.286662614789836,"CDK2",1
"R-HSA-109582","R-HSA-109582","Hemostasis","4/30","298/2914",0.36857444226894,0.422165384913386,0.286662614789836,"AKT1/MAPK14/GATA3/CDK2",4
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/30","45/2914",0.374530433575312,0.426456481888113,0.289576394846305,"STAT1",1
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","1/30","45/2914",0.374530433575312,0.426456481888113,0.289576394846305,"CDK2",1
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/30","46/2914",0.381070721826528,0.432627348897176,0.293766593606209,"UBE2I",1
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","1/30","47/2914",0.387544877455958,0.436129220693877,0.296144466737866,"EP300",1
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","1/30","47/2914",0.387544877455958,0.436129220693877,0.296144466737866,"CREB1",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/30","47/2914",0.387544877455958,0.436129220693877,0.296144466737866,"STAT1",1
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","1/30","48/2914",0.393953546335038,0.442052525829432,0.300166563762008,"EP300",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","1/30","49/2914",0.400297368250582,0.445287562376728,0.302363247973289,"STAT1",1
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","1/30","49/2914",0.400297368250582,0.445287562376728,0.302363247973289,"EP300",1
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","1/30","49/2914",0.400297368250582,0.445287562376728,0.302363247973289,"CREB1",1
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","1/30","50/2914",0.40657697696,0.4501076217372,0.30563620892436,"MEN1",1
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","1/30","51/2914",0.412793000246033,0.4501076217372,0.30563620892436,"EP300",1
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","1/30","51/2914",0.412793000246033,0.4501076217372,0.30563620892436,"EP300",1
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","1/30","51/2914",0.412793000246033,0.4501076217372,0.30563620892436,"EP300",1
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","1/30","51/2914",0.412793000246033,0.4501076217372,0.30563620892436,"EP300",1
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","1/30","51/2914",0.412793000246033,0.4501076217372,0.30563620892436,"EP300",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/30","51/2914",0.412793000246033,0.4501076217372,0.30563620892436,"CDK2",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/30","53/2914",0.425036772130647,0.460854477647274,0.312933637671588,"CSNK2A1",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/30","53/2914",0.425036772130647,0.460854477647274,0.312933637671588,"PAK1",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","2/30","144/2914",0.44118247401766,0.477020826248786,0.323911060092576,"AKT1/AKT3",2
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","1/30","56/2914",0.442940896291473,0.477584318347789,0.324293687670029,"CSNK2A1",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/30","57/2914",0.448788262670499,0.48254114036438,0.327659514455224,"CTNNB1",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","1/30","59/2914",0.460305516118625,0.492182629423239,0.334206366856795,"CREB1",1
"R-HSA-202403","R-HSA-202403","TCR signaling","1/30","59/2914",0.460305516118625,0.492182629423239,0.334206366856795,"PAK1",1
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","1/30","61/2914",0.471589982350782,0.501470339359233,0.34051299291096,"MEN1",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/30","61/2914",0.471589982350782,0.501470339359233,0.34051299291096,"CSNK2A1",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","2/30","153/2914",0.472967873138957,0.50155384349351,0.340569694654715,"AKT1/MAPK14",2
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","1/30","62/2914",0.477146344260868,0.503219914985506,0.341701005812356,"PAK1",1
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","1/30","62/2914",0.477146344260868,0.503219914985506,0.341701005812356,"CDK2",1
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","1/30","63/2914",0.482646207399779,0.507633340752901,0.344697850688498,"MEN1",1
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","1/30","64/2914",0.488090126648466,0.510576663648531,0.346696452818337,"EP300",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/30","64/2914",0.488090126648466,0.510576663648531,0.346696452818337,"PAK1",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","2/30","160/2914",0.496987509617028,0.518478861384251,0.352062275660427,"AKT1/AKT3",2
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/30","66/2914",0.498812326763113,0.518979941052727,0.352402523376409,"EP300",1
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","1/30","68/2914",0.509317279377659,0.528485133977894,0.358856826726195,"PAK1",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","1/30","72/2914",0.529692373541287,0.548153501841653,0.372212222412249,"ESR2",1
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","1/30","86/2914",0.594761602755668,0.613844862737133,0.416818573279373,"MEN1",1
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","1/30","87/2914",0.599060454211584,0.61663289420179,0.418711727996307,"PAK1",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","3/30","296/2914",0.600877856416536,0.616858650470167,0.418865023089914,"AKT1/PAK1/AKT3",3
"R-HSA-913531","R-HSA-913531","Interferon Signaling","1/30","97/2914",0.63969427950792,0.654965495729595,0.444740682947012,"STAT1",1
"R-HSA-68886","R-HSA-68886","M Phase","1/30","105/2914",0.669306558650739,0.683471776823241,0.464097279599092,"CSNK2A1",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","4/30","436/2914",0.677549050161397,0.690063148713191,0.468573013443099,"AKT1/CREB1/PAK1/AKT3",4
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","1/30","109/2914",0.683216327471237,0.692182421007605,0.470012061169604,"EP300",1
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","1/30","109/2914",0.683216327471237,0.692182421007605,0.470012061169604,"EP300",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","1/30","125/2914",0.73341044279002,0.741090133290439,0.503221824895881,"MAPK14",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/30","126/2914",0.736278024975857,0.742045215772013,0.503870353769379,"CTNNB1",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","4/30","486/2914",0.762289063747544,0.766259319287896,0.520312436603998,"AKT1/CREB1/PAK1/AKT3",4
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","1/30","165/2914",0.827560314646447,0.829709821957217,0.563397179349188,"CREB1",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","1/30","217/2914",0.903063183142121,0.903063183142121,0.613206251983606,"CREB1",1
